Abiopharma

🔍 SCHORSCH NICHOLAS S (Executive)

Company: American Strategic Investment Co. (NYC)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Acquired 160,766 shares of Class A common stock at $6.98 per share (Direct)
  Date: 2026-08-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,165,233.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 5,000 shares of Class A common stock at $6.81 per share (Direct)
  Date: 2026-08-26 | Code: P | equity_swap_involved: 0 | shares_owned_after: 794,620.00 | transaction_form_type: 4 | Footnotes: F3, F4
• Acquired 5,000 shares of Class A common stock at $6.68 per share (Direct)
  Date: 2026-08-27 | Code: P | equity_swap_involved: 0 | shares_owned_after: 799,620.00 | transaction_form_type: 4 | Footnotes: F5, F4
• Holds 0 shares of Class A common stock (Direct)
  Date: 2026-08-25 | Code: H | shares_owned_after: 26,559.00 | Footnotes: F6

Footnotes:

• F1: Fully-vested shares of Class A common stock of American Strategic Investment Co. (the "Issuer") issued pursuant to the 2020 Advisor Omnibus Incentive Compensation Plan of the Issuer to, and in connection with fees earned by, New York City Advisors, LLC, the external advisor of the Issuer (the "Advisor").
• F2: Mr. Nicholas S. Schorsch is the sole managing member of Bellevue Capital Partners, LLC ("BCP"), who is the ultimate controlling person of the Advisor, and has voting and investment discretion with respect to the securities held of record by the Advisor. BCP is the sole member of AR Global Investments, LLC, who is the sole member of American Realty Capital III, LLC ("ARC III"). ARC III is the sole member of New York City Special Limited Partnership, LLC, who is the sole member of the Advisor, the record holder of the securities reported herein.
• F3: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.35-$6.84, inclusive. The Reporting Persons undertake to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
• F4: Represents shares of Class A common stock directly owned by BCP. Mr. Nicholas S. Schorsch is the sole managing member of BCP, and has voting and investment discretion with respect to the securities held of record by BCP.
• F5: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.26-$6.77, inclusive. The Reporting Persons undertake to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
• F6: Represents shares of Class A common stock directly owned by Mr. Schorsch.
• REMARKS: Exhibit 99.1 - Joint Filer Information, which is incorporated herein by reference and describes in further detail the relationships of the Reporting Persons to the Issuer. // The Reporting Persons are filing this Form 4 because they may be deemed to be members of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding common stock. The Reporting Persons expressly disclaim beneficial ownership of the securities beneficially owned by the other group members. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.